KR100696924B1 - 피로 개선제 - Google Patents
피로 개선제 Download PDFInfo
- Publication number
- KR100696924B1 KR100696924B1 KR1020057013471A KR20057013471A KR100696924B1 KR 100696924 B1 KR100696924 B1 KR 100696924B1 KR 1020057013471 A KR1020057013471 A KR 1020057013471A KR 20057013471 A KR20057013471 A KR 20057013471A KR 100696924 B1 KR100696924 B1 KR 100696924B1
- Authority
- KR
- South Korea
- Prior art keywords
- fatigue
- coenzyme
- improving agent
- vitamin
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
- A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
보효소 Q 량 (㎍/g) | |||
Q10 | Q9 | 총 CoQ | |
대조군 | 0.73±0.18 (100) | 9.62±2.33 (100) | 10.35±2.52 (100) |
환원형 보효소 Q10 군 | 0.57±0.21 (215**) | 15.82±2.89 (164*) | 17.39±3.09 (168*) |
산화형 보효소 Q10 군 | 1.34±0.16 (184**) | 12.84±2.03 (133) | 14.18±2.18 (137) |
환원형 보효소 Q 량 (㎍/g) | |||
Q10 | Q9 | 총 CoQ | |
대조군 | 0.32±0.06 (100) | 3.28±0.59 (100) | 3.60±0.63 (100) |
환원형 보효소 Q10 군 | 0.39±0.24 (122) | 5.32±1.07 (162*) | 5.71±1.16 (159*) |
산화형 보효소 Q10 군 | 0.11±0.10 (34**) | 2.34±0.42 (71*) | 2.45±0.44 (68*) |
최대 주행 시간 (초) | |||
투여 전 | 투여 후 | 연장 시간 | |
용매 대조 | 1542±105 (100) | 1598±104 (100) | 56.1±50.2 (100) |
환원형 보효소 Q10 300mg/kg | 1523±97 (99) | 1719±160 (108*) | 196±127 (349**) |
산화형 보효소 Q10 300mg/kg | 1543±99 (100) | 1733±107 (108**) | 190±76 (339**) |
최대 주행 시간 (초) | |||
투여 전 | 투여 후 | 연장 시간 | |
용매 대조 | 861±123 (100) | 836±121 (100) | -25±24 |
환원형 보효소 Q10 300mg/kg | 861±123 (100) | 958±52* (115) | 97±28** |
산화형 보효소 Q10 300mg/kg | 861±123 (100) | 875±108 (105) | 14±43 |
Claims (29)
- 제 1 항 또는 제 2 항에 있어서, 보효소 Q 가 보효소 Q10 인 피로 개선제.
- 제 1 항 또는 제 2 항에 있어서, 항산화 물질 또는/및 항산화 효소를 함유하는 피로 개선제.
- 제 4 항에 있어서, 항산화 물질이 비타민 E, 비타민 E 유도체, 비타민 C, 비타민 C 유도체, 프로부콜, 리코펜, 비타민 A, 카로테노이드류, 비타민 B, 비타민 B 유도체, 플라보노이드류, 폴리페놀류, 글루타티온, 피롤로퀴놀린퀴논, 피크노제놀, 플라바제놀, 또는 셀렌인 피로 개선제.
- 제 4 항에 있어서, 항산화 효소가 슈퍼옥시드디스무타제 (SOD), 글루타티온퍼옥시다아제, 글루타티온-S-트란스페라제, 글루타티온 환원 효소, 카탈라제, 또는 아스코르브산퍼옥시다아제인 피로 개선제.
- 제 1 항 또는 제 2 항에 있어서, 자양 강장 성분을 함께 함유하는 피로 개선제.
- 제 7 항에 있어서, 자양 강장 성분이 크레아틴, 타우린, 비타민 B1, 비타민 B 유도체, 또는 아미노산인 피로 개선제.
- 제 1 항 또는 제 2 항에 있어서, 영양 보조 성분을 함유하는 피로 개선제.
- 제 9 항에 있어서, 영양 보조 성분이 아미노산, 금속 이온, 당류, 단백질류, 지방산류, 또는 비타민인 피로 개선제.
- 제 1 항 또는 제 2 항에 있어서, 그 형태가 드링크제 혹은 식품인 피로 개선제.
- 제 1 항 또는 제 2 항에 있어서, 피부에 직접 도포함으로써 근육 피로를 개선하는 피로 개선제.
- 제 12 항에 있어서, 그 형태가 스프레이제, 연고제, 리니멘트제, 로션제, 크림제, 습포제, 플라스터제, 테이프제인 피로 개선제.
- 제 12 항에 있어서, 항염증 성분을 함께 함유하는 피로 개선제.
- 제 14 항에 있어서, 항염증 성분이 스테로이드, 살리실산 및 그 유도체, 아릴아세트산 및 그 유도체, 프로피온산 및 그 유도체, 페남산 및 그 유도체, 피라졸론 및 그 유도체, 옥시캄 및 그 유도체, 및 비산성 항염증제로 이루어지는 군으로 부터 선택되는 1 종 이상인 피로 개선제.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제 1 항 또는 제 2 항에 있어서, 근육 피로 개선제인 것을 특징으로 하는 피로 개선제.
- 제 1 항 또는 제 2 항에 있어서, 중노년층용 피로 개선제인 것을 특징으로 하는 피로 개선제.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JPJP-P-2003-00024758 | 2003-01-31 | ||
JP2003024758 | 2003-01-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20050092128A KR20050092128A (ko) | 2005-09-20 |
KR100696924B1 true KR100696924B1 (ko) | 2007-03-20 |
Family
ID=32820773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020057013471A KR100696924B1 (ko) | 2003-01-31 | 2004-01-19 | 피로 개선제 |
Country Status (11)
Country | Link |
---|---|
US (1) | US8946303B2 (ko) |
EP (1) | EP1588703B1 (ko) |
JP (1) | JP4644121B2 (ko) |
KR (1) | KR100696924B1 (ko) |
CN (1) | CN1723015A (ko) |
AU (1) | AU2004208588B2 (ko) |
CA (1) | CA2511080C (ko) |
NO (1) | NO20053051L (ko) |
RU (1) | RU2304432C2 (ko) |
TW (1) | TWI322008B (ko) |
WO (1) | WO2004066988A1 (ko) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2550186A1 (en) * | 2004-01-08 | 2005-07-21 | Kaneka Corporation | Antiaging composition |
US7708990B2 (en) * | 2004-03-23 | 2010-05-04 | Kaneka Corporation | Coenzyme Q compositions persisting in blood |
AU2005224245A1 (en) * | 2004-03-23 | 2005-09-29 | Kaneka Corporation | Coenzyme Q composition with long-term persistence in blood |
TW200603786A (en) * | 2004-05-11 | 2006-02-01 | Kaneka Corp | Anti-fatigue composition |
TW200722076A (en) * | 2005-03-29 | 2007-06-16 | Kaneka Corp | Composition for increasing anti-oxidation activity in blood |
EP1897539B1 (en) * | 2005-06-24 | 2012-10-31 | Kaneka Corporation | Anti-fatigue composition |
JP5023253B2 (ja) * | 2005-09-14 | 2012-09-12 | 株式会社ノエビア | 疲労感、倦怠感の予防及び治療用組成物 |
JP5103374B2 (ja) * | 2006-03-13 | 2012-12-19 | 株式会社カネカ | 心機能不良改善剤または心機能維持剤 |
EP3173068B1 (en) | 2006-05-02 | 2020-09-09 | University of Miami | Topical co-enzyme q10 formulations and treatment of wounds |
WO2008007728A1 (fr) * | 2006-07-13 | 2008-01-17 | Kaneka Corporation | Préparation orale contenue dans une structure à membrane lipidique, et agent contre la fatigue comprenant une coenzyme comme ingrédient actif |
JP2008239528A (ja) * | 2007-03-26 | 2008-10-09 | Lion Corp | 目及び脳機能改善剤 |
GB2450117A (en) * | 2007-06-13 | 2008-12-17 | Reckitt Benckiser Healthcare | A water- and oxygen-occlusive blister tablet pack |
JP5283359B2 (ja) * | 2007-08-30 | 2013-09-04 | 株式会社カネカ | 還元型補酵素q含有組成物 |
JP5558823B2 (ja) * | 2007-10-05 | 2014-07-23 | 株式会社カネカ | 還元型補酵素q10の製造方法 |
IL188681A0 (en) * | 2008-01-09 | 2008-12-29 | Amino Acid Solutions Inc | Pharmaceutical compositions and methods utilizing a d-amino acid |
JPWO2009136587A1 (ja) * | 2008-05-08 | 2011-09-08 | 株式会社カネカ | 抗疲労組成物 |
CN105815770A (zh) * | 2009-01-23 | 2016-08-03 | 惠氏有限责任公司 | 不具有大剂量的营养补充剂的副作用的多种维生素/矿物质制剂 |
US9040747B2 (en) | 2009-10-16 | 2015-05-26 | Kaneka Corporation | Method for producing reduced coenzyme Q10, method for stabilizing same, and composition comprising same |
US8865660B2 (en) | 2010-12-10 | 2014-10-21 | Broady Health Sciences, Llc | Method of treating neurogenic overactive bladder in a mammal or method of treating non-psychological stress-related bladder dysfunction in a female mammal by administering at least on jasmonate |
JP6024942B2 (ja) * | 2012-02-29 | 2016-11-16 | 株式会社福山こめ酢 | テストステロン分泌促進剤、抗疲労剤及びその製造方法と利用 |
CN103371317A (zh) * | 2012-04-25 | 2013-10-30 | 山东邦奥创业生物科技有限公司 | 一种核糖功能食品 |
WO2014153285A1 (en) * | 2013-03-16 | 2014-09-25 | Sinatra Stephen T | Equine supplement |
RU2540476C1 (ru) * | 2014-03-27 | 2015-02-10 | Федеральное государственное унитарное предприятие "Государственный ордена Трудового Красного Знамени научно-исследовательский институт химии и технологии элементоорганических соединений" (ФГУП "ГНИИХТЭОС") | Повышение работоспособности |
RU2018108109A (ru) * | 2015-08-11 | 2019-09-12 | Акаал Фарма Пти Лтд | Композиции с модуляторами s1p рецептора |
CN107007606B (zh) * | 2016-02-04 | 2021-10-26 | 南京舒鹏生物科技有限公司 | 一种用于干燥综合症预防及治疗的药物及其组合 |
CN106177925A (zh) * | 2016-08-25 | 2016-12-07 | 明光市昊昊蜂业有限公司 | 一种蜂王浆美容保健品 |
JP6252922B2 (ja) * | 2016-09-27 | 2017-12-27 | ビーエイチエヌ株式会社 | テストステロン分泌促進剤、抗疲労剤及びその製造方法と利用 |
CN106617030A (zh) * | 2016-12-12 | 2017-05-10 | 钦州学院 | 一种体力恢复剂及其制备方法 |
KR20200015549A (ko) | 2017-05-17 | 2020-02-12 | 버그 엘엘씨 | 수포성 표피박리증의 치료 및 예방에서 조효소 q10 제형의 용도 |
US11471426B2 (en) | 2019-10-16 | 2022-10-18 | American River Nutrition, Llc | Compositions comprising quinone and/or quinol and methods of preparations and use thereof |
CN110801018A (zh) * | 2019-11-08 | 2020-02-18 | 广东医科大学 | 辅酶q10维生素c运动含片 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5942649B2 (ja) * | 1976-02-14 | 1984-10-16 | エーザイ株式会社 | 重症筋無力症治療剤 |
JPS5938204B2 (ja) * | 1976-02-14 | 1984-09-14 | エーザイ株式会社 | 再生不良性貧血治療剤 |
US6444221B1 (en) * | 1992-06-30 | 2002-09-03 | Howard K. Shapiro | Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
JPH07330584A (ja) | 1994-06-08 | 1995-12-19 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
JPH07330593A (ja) * | 1994-06-09 | 1995-12-19 | Taisho Pharmaceut Co Ltd | 疲労改善剤 |
JPH1053520A (ja) * | 1996-06-03 | 1998-02-24 | Takeda Chem Ind Ltd | 抗疲労剤 |
JP3889481B2 (ja) * | 1996-08-16 | 2007-03-07 | 株式会社カネカ | 医薬組成物 |
DK0969744T3 (da) * | 1997-03-27 | 2003-06-23 | Khursheed N Jeejeebhoy | Kosttilskud til forbedringer af celleenergetik |
JPH10287560A (ja) * | 1997-04-11 | 1998-10-27 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
DE19806947A1 (de) | 1998-02-19 | 1999-08-26 | Beiersdorf Ag | Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen |
AU3930600A (en) * | 1999-03-30 | 2000-10-16 | Purdue Research Foundation | Methods for identifying agents that inhibit serum aging factors and uses and compositions thereof |
WO2001001962A1 (en) * | 1999-07-05 | 2001-01-11 | Idea Ag. | A method for the improvement of transport across adaptable semi-permeable barriers |
WO2001032040A1 (en) * | 1999-11-01 | 2001-05-10 | University Of Massachusetts | Method for selective delivery of lipid-soluble antioxidants into the polar lipid fraction of a food product |
KR20030016202A (ko) | 1999-11-24 | 2003-02-26 | 액세스 비지니스 그룹 인터내셔날 엘엘씨 | 국소성 피부 조성물 |
US8753675B1 (en) | 2000-01-20 | 2014-06-17 | Raj K. Chopra | Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications |
JP4421801B2 (ja) * | 2000-05-09 | 2010-02-24 | 株式会社カネカ | 補酵素qを有効成分とする皮膚用組成物 |
ZA200109677B (en) * | 2000-09-06 | 2002-06-25 | Technikon Pretoria | A nutritional and pharmaceutical composition. |
JP2002363073A (ja) * | 2001-05-09 | 2002-12-18 | Crescendo Corporation | スポーツパフォーマンス |
AU2002309038B2 (en) * | 2001-05-10 | 2007-05-17 | Kaneka Corporation | Compositions for transmucosal administration containing coenzyme Q as the active ingredient |
JP2003119127A (ja) | 2001-10-10 | 2003-04-23 | Kanegafuchi Chem Ind Co Ltd | 安定な還元型補酵素q製剤 |
TWI329513B (en) * | 2001-10-12 | 2010-09-01 | Kaneka Corp | Use of reduced coenzyme q for lessening oxidative stress |
-
2004
- 2004-01-15 TW TW093101022A patent/TWI322008B/zh not_active IP Right Cessation
- 2004-01-19 EP EP04703268.5A patent/EP1588703B1/en not_active Expired - Lifetime
- 2004-01-19 RU RU2005122409/15A patent/RU2304432C2/ru not_active IP Right Cessation
- 2004-01-19 KR KR1020057013471A patent/KR100696924B1/ko active IP Right Grant
- 2004-01-19 CA CA2511080A patent/CA2511080C/en not_active Expired - Lifetime
- 2004-01-19 US US10/541,020 patent/US8946303B2/en active Active
- 2004-01-19 JP JP2005504674A patent/JP4644121B2/ja not_active Expired - Lifetime
- 2004-01-19 AU AU2004208588A patent/AU2004208588B2/en not_active Expired
- 2004-01-19 CN CNA200480001744XA patent/CN1723015A/zh active Pending
- 2004-01-19 WO PCT/JP2004/000366 patent/WO2004066988A1/ja active Application Filing
-
2005
- 2005-06-21 NO NO20053051A patent/NO20053051L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1723015A (zh) | 2006-01-18 |
AU2004208588B2 (en) | 2009-05-07 |
JP4644121B2 (ja) | 2011-03-02 |
EP1588703B1 (en) | 2016-04-20 |
JPWO2004066988A1 (ja) | 2006-05-18 |
EP1588703A4 (en) | 2008-06-11 |
CA2511080A1 (en) | 2004-08-12 |
TWI322008B (en) | 2010-03-21 |
US8946303B2 (en) | 2015-02-03 |
US20060165672A1 (en) | 2006-07-27 |
RU2005122409A (ru) | 2006-01-20 |
WO2004066988A1 (ja) | 2004-08-12 |
NO20053051L (no) | 2005-08-31 |
EP1588703A1 (en) | 2005-10-26 |
RU2304432C2 (ru) | 2007-08-20 |
NO20053051D0 (no) | 2005-06-21 |
AU2004208588A2 (en) | 2004-08-12 |
TW200501936A (en) | 2005-01-16 |
CA2511080C (en) | 2015-10-13 |
KR20050092128A (ko) | 2005-09-20 |
AU2004208588A1 (en) | 2004-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100696924B1 (ko) | 피로 개선제 | |
US20070259908A1 (en) | Mitochondria Activators | |
EP1897539B1 (en) | Anti-fatigue composition | |
US7708990B2 (en) | Coenzyme Q compositions persisting in blood | |
EP1747778B1 (en) | Anti-fatigue composition | |
EP1728506A1 (en) | Coenzyme q composition with long-term persistence in blood | |
WO2009136587A1 (ja) | 抗疲労組成物 | |
KR20080097437A (ko) | 혈압 정상화 조성물 | |
JP5103374B2 (ja) | 心機能不良改善剤または心機能維持剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130227 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140220 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150224 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160218 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170220 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180219 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20200218 Year of fee payment: 14 |